Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency: A Phase II Clinical and Exploratory Biomarker Study of Talazoparib
Latest Information Update: 07 Sep 2022
At a glance
- Drugs Talazoparib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 21 May 2021 New trial record